TPO mimetics are drugs used for the treatment of immune thrombocytopenia, characterized by accelerated platelet clearance from the circulation and low platelet count and PCT (Kuter, 2009; Tang et al., 2017). Here, TPO is linked to autoimmune thrombocytopenic purpura.